Search

everythinglearnresearchcommunity

for

Search:↓

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

The document suggests that male hormones likely affect hair growth and baldness, and future treatments might involve stem cells and androgen-independent cells.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

Injecting platelet-rich plasma into the scalp stimulates hair growth, increases hair density, and treats hair loss effectively with minimal side effects.

Platelet-rich plasma (PRP) injections effectively treat hair loss and thinning in both men and women, with high satisfaction and no major side effects.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Mcl-1 can activate Wnt signaling in skin cells, promoting growth and possibly cancer.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

PCFCL may have unrecognized subtypes and needs more research.

BCC can protect heart cells from damage caused by oxidative stress.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Calancardin B may help reduce inflammation in immune cells.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

pCLCA2 protein may help maintain skin structure and function.

A new platinum complex was made and studied, which might help fight cancer better.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Basal cell carcinomas may use IDO to protect themselves from the immune system.